Gerontology

Clinical Section

Acute Confusion or Altered Mental State: Consider Nonconvulsive Status Epilepticus

Beyenburg S.a · Elger C.E.b · Reuber M.c

Author affiliations

aDepartment of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg; bDepartment of Epileptology, University of Bonn, Bonn, Germany; cAcademic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK

Related Articles for ""

Gerontology 2007;53:150–158

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve

  • Unlimited fulltext viewing Of this article
  • Organize, annotate And mark up articles
  • Printing And downloading restrictions apply

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Clinical Section

Received: March 20, 2007
Accepted: June 05, 2007
Published online: August 07, 2007
Issue release date: May 2008

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER

Abstract

Background: The diagnosis of nonconvulsive status epilepticus (NCSE) is particularly challenging in elderly patients. Confusion, personality change, dysphasia, subtle motor activity and nystagmus may be the only presenting signs. Objective: To review current knowledge about NCSE with special focus on older people. Methods: Systematic review of the current literature via Medline search. Conclusion: Although prospective studies are still lacking, NCSE may be one of the most frequently missed diagnoses in patients presenting with altered mental status. Elderly patients are at particular risk of diagnostic errors because of the broad range of presentations of NCSE, significant comorbidities (especially cerebrovascular disease), limited awareness of this particular seizure emergency or difficulties with access to electroencephalography. Although diagnostic criteria and treatment remain controversial, the diagnosis of NCSE is important because it is potentially reversible.

© 2007 S. Karger AG, Basel




Related Articles:


References

  1. Hauser WA, Annegers JF, Kurland LT: Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia 1991;32:429–445.
  2. Bergey GK: Initial treatment of epilepsy. Special issues in treating the elderly. Neurology 2004;63(suppl 4):S40–S48.
  3. Van Cott AC: Epilepsy and EEG in the elderly. Epilepsia 2002;43(suppl 3):94–102.
  4. Collins NS, Shapiro RA, Ramsay RE: Elders with epilepsy. Med Clin North Am 2006;90:945–966.
  5. Chin RFM, Neville BGR, Scott RC: A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004;11:800–810.
  6. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029–1035.
  7. Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, Walczak T: Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006;68(suppl 1):S39–S48.
  8. Treiman DM, Walker MC: Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res 2006;68(suppl 1):S77–S82.
  9. Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, DeLorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, Kaplan P, Koutroumanidis M, O’Regan M, Plouin P, Sander J, Scott R, Shorvon S, Treiman D, Wasterlain C, Wieshmann U: Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 2005;7:253–296.
  10. Charcot JM: Leçon du 31 Janvier 1888; in Leçon du mardi. Paris, Progès médical, 1888, vol 1, pp 155–169.
  11. Lennox W: The petit mal epilepsies: their treatment with tridione. JAMA 1945;129:1069–1073.
    External Resources
  12. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792–798.
  13. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, DeLorenzo RJ: Prevalence of nonconvulsive status epilepticus in comatosed patients. Neurology 2000;54:340–345.
  14. Drislane FW: Presentation, evaluation, and treatment of nonconvulsive status epilepticus. Epilepsy Behav 2000;1:301–304.
  15. Kaplan PW: The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 2005;11:348–361.
  16. Riggio S: Nonconvulsive status epilepticus: clinical features and diagnostic challenges. Psychiatr Clin North Am 2005;28:653–864.
  17. Riggio S: Psychiatric manifestations of nonconvulsive status epilepticus. Mt Sinai J Med 2006;73:960–966.
  18. Zambrelli E, Terzaghi M, Sinforiani E: Non-convulsive status epilepticus and generalised tonic-clonic seizures persisting in old age in a patient with idiopathic generalised epilepsy: a long-term observation. Neurol Sci 2006;27:436–438.
  19. Bauer G, Bauer R, Dobesberger J, Benke T, Walser G, Trinka E: Absence status in the elderly as a late complication of idiopathic generalized epilepsies. Epileptic Disord 2007;9:39–42.
  20. Langheinrich TC, Chattopadhyay A, Kuc S, Reuber M: Prolonged postical stupor: nonconvulsive status epilepticus, medication effect, or postictal state? Epilepsy Behav 2005;7:548–551.
  21. Cascino GD: Nonconvulsive status epilepticus in adults and children. Epilepsia 1993;34(suppl 1):S21–S28.
  22. Litt B, Wityk RJ, Hertz SH, Mullen PD, Weiss H, Ryan DD, Henry TR: Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998;39:1194–1202.
  23. Wasterlain CG, Chen JW: Definition and classification of status epilepticus; in Wasterlain CG, Treiman DM (eds): Status Epilepticus. Mechanisms and Management. Cambridge, MIT Press, 2006, pp 11–16.
  24. Manno EM, Pfeifer EA, Cascino GD, Noe KH, Wijdicks EF: Cardiac pathology in status epilepticus. Ann Neurol 2005;58:954–957.
  25. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM: Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1499–1504.
  26. Krumholz A: Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:314–322.
  27. Jordan KG, Hirsch LJ: In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 2006;47 (suppl 1):41–45.
  28. Fernandez-Torre JL, Diaz-Castroverde AG: Non-convulsive status epilepticus in elderly individuals: report of four representative cases. Age Ageing 2004;33:78–81.
  29. Husain AM, Horn GJ, Jacobson MP: Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry 2003;74:189–191.
  30. Haffey S, McKernan A, Pang K: Non-convulsive status epilepticus: a profile of patients diagnosed within a tertiary referral centre. J Neurol Neurosurg Psychiatry 2004;75:1043–1044.
  31. Blitshteyn S, Jaeckle KA: Nonconvulsive status epilepticus in metastatic CNS disease. Neurology 2006;66:1261–1263.
  32. Kaplan PW: Nonconvulsive status epilepticus in the emergency room. Epilepsia 1996;37:643–650.
  33. Reuber M, Evans J, Bamford JM: Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002;9:111–112.
  34. Profitlich T, Hoppe C, Reuber M, Helmstaedter C, Bauer J: Ictal neuropsychological findings in focal nonconvulsive status epilepticus, submitted.
  35. Sheth RD, Drazkowski JF, Sirven JI, Gidal BE, Hermann BP: Protracted ictal confusion in elderly patients. Arch Neurol 2006;63:529–532.
  36. Kaplan PW: Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status is underdiagnosed, potentially overtreated and confounded by comorbidity. J Clin Neurophysiol 1999;16:341–352.
  37. Granner MA, Lee SI: Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 1994;35:42–47.
  38. Kalita J, Misra UK, Patel R: Initial EEG in status epilepticus is helpful in predicting seizure recurrence. Electromyogr Clin Neurophysiol 2006;46:139–144.
  39. Hormigo A, Liberato B, Lis E, DeAngelis LM: Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities. Arch Neurol 2004;61:362–365.
  40. Manno EM: New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003;78:508–518.
  41. Chen JW, Wasterlain CH: Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006;5:246–256.
  42. Young GB, Jordan KG: Do nonconvulsive seizures damage the brain? – Yes. Arch Neurol 1998;55:117–119.
  43. Aminoff MJ: Do nonconvulsive seizures damage the brain? – No. Arch Neurol 1998;55:119–120.
  44. Young GB, Jordan KG, Doig GS: An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996;47:83–89.
  45. Kaplan PW: No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: ‘the cure may be worse than the disease’). Neurophysiol Clin 2000;30:377–382.
  46. Arroyo S, Kramer G: Treating epilepsy in the elderly: safety considerations. Drug Saf 2001;24:991–1015.
  47. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G: Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2006; Epub ahead of print.
  48. Rossetti AO, Bromfield EB: Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8:651–654.
  49. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN: The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137–141.
  50. Beyenburg S, Bauer J, Reuber M: New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J 2004;80:581–587.
  51. Waterhouse EJ, Vaughan JK, Barnes TY, Boggs JG, Towne AR, Kopec-Garnett L, DeLorenzo RJ: Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998;29:175–183.
  52. Shneker BF, Fountain NB: Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003;61:1066–1073.
  53. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB: Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006;77:611–615.
  54. Fujikawa DG: The two faces of electrographic status epilepticus. The walking wounded and the ictally comatose; in Wasterlain CG, Treiman DM (eds): Status Epilepticus. Mechanisms and Management. Cambridge, MIT Press, 2006, pp 109–112.
  55. Meldrum BS: Why and when are seizures bad for the brain? Trends Pharmacol Sci 2001;22:445–446.
  56. Leppik IE, Kelly KM, deToledo-Morrell L, Patrylo PR, DeLorenzo RJ, Mathern GW, White HS: Basic research in epilepsy and aging. Epilepsy Res 2006;68(suppl 1):S21–S37.
  57. Drislane FW: Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:323–331.

Article / Publication Details

First-Page Preview
Abstract of Clinical Section

Received: March 20, 2007
Accepted: June 05, 2007
Published online: August 07, 2007
Issue release date: May 2008

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP